Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2025)

Revolution Medicines (RVMD) has 7 years of Goodwill & Intangibles data on record, last reported at $14.6 million in Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 79.25% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $14.6 million, down 79.25%, while the annual FY2025 figure was $14.6 million, 79.25% down from the prior year.
  • Goodwill & Intangibles reached $14.6 million in Q4 2025 per RVMD's latest filing, roughly flat from $14.6 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $77.9 million in Q1 2021 and bottomed at $14.6 million in Q2 2021.
  • Average Goodwill & Intangibles over 5 years is $44.1 million, with a median of $42.5 million recorded in 2021.
  • The widest YoY moves for Goodwill & Intangibles: up 433.19% in 2022, down 81.24% in 2022.
  • A 5-year view of Goodwill & Intangibles shows it stood at $74.5 million in 2021, then decreased by 1.44% to $73.4 million in 2022, then dropped by 4.1% to $70.4 million in 2023, then changed by 0.0% to $70.4 million in 2024, then crashed by 79.25% to $14.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $14.6 million in Q4 2025, $14.6 million in Q3 2025, and $14.6 million in Q2 2025.